Drug ID:   | NPD2148 |
Drug Name:   | |
Molecular Formula:   | C16H21N3O4S2 |
Canonical SMILES:   | C[C@H]([C@H]1C(=O)N2[C@@H]1[C@@H](C)C(=C2C(=O)O)SC1CN(C1)C1=NCCS1)O |
Standard InCHI:   | InChI=1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1 |
Standard InCHIKey:   | GXXLUDOKHXEFBQ-YJFSRANCSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Intermediate Similarity | 0.8235 | NPC59249 |
Remote Similarity | 0.619 | NPC144780 |
Remote Similarity | 0.6131 | NPC288109 |
Remote Similarity | 0.6 | NPC470788 |
Remote Similarity | 0.6 | NPC188785 |
Remote Similarity | 0.5918 | NPC41162 |
Remote Similarity | 0.5852 | NPC296143 |
Remote Similarity | 0.5704 | NPC471259 |
Remote Similarity | 0.5704 | NPC476155 |
Remote Similarity | 0.5704 | NPC17581 |
Remote Similarity | 0.5682 | NPC474985 |
Remote Similarity | 0.5639 | NPC474873 |
Remote Similarity | 0.562 | NPC474099 |
Remote Similarity | 0.5615 | NPC117829 |
Remote Similarity | 0.561 | NPC475342 |
Remote Similarity | 0.5603 | NPC472536 |
Remote Similarity | 0.5603 | NPC50694 |
Remote Similarity | 0.5603 | NPC474984 |
Remote Similarity | 0.5603 | NPC103391 |
Molecular Weight   | 383.10 |
ALogP   | -0.8267 |
MLogP   | 2.23 |
XLogP   | 0.726 |
HDA   | 7 |
HBD   | 2 |
Rotatable Bonds   | 9 |
TPSA   | 144.04 |
RO5 Violation   | 0 |